HomeASND • NASDAQ
add
Ascendis Pharma A/S
Previous close
$156.58
Day range
$150.95 - $158.00
Year range
$111.09 - $158.00
Market cap
9.21B USD
Avg Volume
509.68K
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 173.92M | 26.30% |
Operating expense | 159.51M | 3.01% |
Net income | -38.47M | 55.72% |
Net profit margin | -22.12 | 64.94% |
Earnings per share | -0.64 | 58.44% |
EBITDA | 1.62M | 104.62% |
Effective tax rate | -2.90% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 559.54M | 40.08% |
Total assets | 1.18B | 42.87% |
Total liabilities | 1.29B | 32.32% |
Total equity | -105.71M | — |
Shares outstanding | 59.84M | — |
Price to book | -88.46 | — |
Return on assets | 0.08% | — |
Return on capital | 0.13% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -38.47M | 55.72% |
Cash from operations | -87.18M | -105.26% |
Cash from investing | -384.00K | -105.77% |
Cash from financing | 87.00K | 101.44% |
Net change in cash | -65.97M | -34.35% |
Free cash flow | -104.25M | -279.22% |
About
Founded
2006
Website
Employees
1,017
